The scientific programme focused on the latest advances in the diagnosis and management of inflammatory and systemic autoimmune diseases, including early diagnosis of spondyloarthritis, Still’s disease, biologic and targeted therapies including JAK inhibitors, systemic lupus erythematosus and connective tissue disease-associated interstitial lung disease. The programme also covered osteoarthritis, spinal degeneration, musculoskeletal pain, osteoporosis and osteoporotic fractures, including screening, diagnosis, treatment and emerging pharmacological therapies for osteoporosis.
Bridge Healthcare Representative Office and B.H.C Pharma Co., Ltd. were pleased to accompany the CME programme and introduce quality healthcare products to participating healthcare professionals, contributing to professional knowledge exchange and the advancement of musculoskeletal and autoimmune healthcare in Vietnam.
